Pharma Stocks

Stocks to Watch: Maruti Suzuki, Hyundai, Hero MotoCorp, Aurobindo Pharma and more

Image count1 / 10

Maruti Suzuki | closed the calendar year with its strongest-ever sales performance, highlighting resilient demand despite an SUV-heavy market. The country’s largest carmaker reported its highest sales in 42 years, with combined domestic and export volumes in December crossing 2.17 lakh units, up 32% year-on-year.

Hyundai Motor India share price, Hyundai Motor India stock, Hyundai Motor India shares, Hyundai Motor India, Hyundai Motor India new MD and CEO, Hyundai Motor India MD CEO, Hyundai Motor India MD, Hyundai Motor India CEO,, tarun garg, tarun garg Hyundai Motor India,

Image count2 / 10

Hyundai Motor India Ltd | The company reported total vehicle sales of 58,702 units in December, missing the CNBC-TV18 poll estimate of 62,667 units, even as exports posted strong year-on-year growth. Overall sales rose 6.6% from a year earlier. Domestic volumes stood at 42,416 units, indicating steady demand in the Indian market, while exports continued to drive growth. Overseas shipments jumped 26.5% year-on-year to 16,286 units, reflecting the company’s sustained focus on international markets.

Hero MotoCorp share price, Hero MotoCorp stock, Hero MotoCorp shares, Hero MotoCorp, Hero MotoCorp October sales, Hero MotoCorp monthly sales, Hero MotoCorp sales, Hero MotoCorp sales data, Hero MotoCorp October sales data, Hero MotoCorp Q2, Hero MotoCorp Q2 date, Hero MotoCorp shares decline, Hero MotoCorp shares down,

Image count3 / 10

Hero MotoCorp | The company posted a strong December performance, with total auto sales rising 40% year-on-year to 4.56 lakh units, well above the CNBC-TV18 poll estimate of 4.10 lakh units. Domestic sales led growth, jumping 42.5% to 4.19 lakh units, reflecting robust demand in the Indian market.

Aurobindo Pharma share price, Aurobindo Pharma stock, Aurobindo Pharma shares, Aurobindo Pharma, Aurobindo Pharma arm, Aurobindo Pharma CuraTeQ, CuraTeQ terminates agreement with BIoFactura, Aurobindo Pharma biosimilars,

Image count4 / 10

Aurobindo Pharma Ltd | The pharma company said its wholly owned arm, Auro Pharma Ltd, has acquired the branded non-oncology prescription formulations business of Khandelwal Laboratories Private Ltd on a going-concern basis. The all-cash transaction is valued at ₹3,250 million, subject to working capital adjustments, and does not entail the purchase of shares or the transfer of control of Khandelwal Laboratories.

railtel share price, railtel stock, railtel shares, RailTel order, RailTel Corporation of India, IT infrastructure maintenance, ORGI contract, government digital infrastructure, RailTel revenue, RailTel profit, RailTel share price

Image count5 / 10

RailTel Corporation of India | The company has received a ₹567 crore order from Assam Health Infrastructure Development & Management Society to implement and maintain a Hospital Management Information System, with completion targeted by January 2032.

Image count6 / 10

Indian Bank | State-owned bank reported double-digit year-on-year growth in key balance-sheet metrics for the third quarter of FY26. Total business rose 13.4% to ₹14.30 lakh crore in Q3 FY26, while gross advances increased 14.5% to ₹6.40 lakh crore, indicating continued credit growth.

South Indian Bank | Brokerage: AnandRathi | Rating: Buy | CMP: Rs 11 | Target: Rs 16 | Upside: 45 percent

Image count7 / 10

South Indian Bank | South Indian Bank reported steady business momentum in the December quarter, posting double-digit growth in both advances and deposits. Gross advances rose 11.27% year-on-year to ₹96,765 crore as of December 31, 2025, while total deposits increased 12.17% to ₹1.18 lakh crore. The bank said adjusted loan growth would have been 12.43% after accounting for a technical write-off in March 2025.

Image count8 / 10

Punjab & Sind Bank | The bank reported steady business growth for the quarter ended December 31, 2025, as per provisional figures. Total business rose to ₹2.49 lakh crore, up 3.49% quarter-on-quarter and 11.84% year-on-year, reflecting continued expansion across key balance-sheet parameters.

Image count9 / 10

Time Technoplast | The company has secured PESO and TÜV Rheinland approvals to manufacture 2-litre high-pressure Type-3 composite cylinders for compressed gas applications, becoming the first Indian company authorised for their use across hydrogen, medical, drone and industrial gas segments.

Olectra Greentech share price

Image count10 / 10

Olectra Greentech | Olectra Greentech has begun commercial operations of Phase I of its greenfield EV manufacturing facility in Hyderabad, effective December 31, marking a key step in its electric mobility expansion.

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button